New chairman for Array BioPharma
BOULDER — Array BioPharma Inc. (Nasdaq: ARRY) has a new chairman of its board of directors.
Carrie S. Cox has been named chairman. Kyle Lefkoff, general partner of Boulder Ventures Ltd., has stepped down as chairman and will continue to serve as a director.
Cox has a long history in the biopharmaceutical industry, serving as executive vice president and president of Schering-Plough’s Global Pharmaceutical Business. Prior to that, she was executive vice president and president of Pharmacia’s Global Prescription Business, senior vice president of Pharmacia & Upjohn’s Global Prescription Business, and as vice president of Women’s Healthcare at Wyeth-Ayerst.
SPONSORED CONTENT
Business Cares: March 2024
WomenGive, a program of United Way of Larimer County, was started in Larimer County in 2006 as an opportunity for women in our community to come together to help other women.
BOULDER — Array BioPharma Inc. (Nasdaq: ARRY) has a new chairman of its board of directors.
Carrie S. Cox has been named chairman. Kyle Lefkoff, general partner of Boulder Ventures Ltd., has stepped down as chairman and will continue to serve as a director.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!